XML 13 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
At The Market Offerings [Member]
Common Stock
Common Stock
At The Market Offerings [Member]
Additional Paid-In Capital
Additional Paid-In Capital
At The Market Offerings [Member]
Accumulated Other Comprehensive Income
Retained Earnings
Beginning balance at Dec. 31, 2022 $ 1,235,584   $ 9   $ 2,420,223   $ (7,461) $ (1,177,187)
Beginning balance, shares at Dec. 31, 2022     87,103,007          
Issuance of common stock   $ 1,466       $ 1,466    
Issuance of common stock, shares       35,349        
Contingent consideration paid, shares     567,045          
Contingent consideration paid 24,126       24,126      
Exercise of stock options 755       755      
Exercise of stock options, shares     48,353          
Vesting of restricted stock units, shares     342,025          
Stock-based compensation 27,255       27,255      
Other comprehensive gain (loss) - unrealized gain (loss) on marketable securities 2,989           2,989  
Other comprehensive gain (loss) - equity method investment 1,794           1,794  
Net Income (Loss) (103,126)             (103,126)
Ending balance at Mar. 31, 2023 1,190,843   $ 9   2,473,825   (2,678) (1,280,313)
Ending balance, shares at Mar. 31, 2023     88,095,779          
Beginning balance at Dec. 31, 2022 1,235,584   $ 9   2,420,223   (7,461) (1,177,187)
Beginning balance, shares at Dec. 31, 2022     87,103,007          
Other comprehensive gain (loss) - equity method investment 2,086              
Net Income (Loss) (226,807)              
Ending balance at Jun. 30, 2023 1,104,888   $ 9   2,512,741   (3,868) (1,403,994)
Ending balance, shares at Jun. 30, 2023     88,347,634          
Beginning balance at Mar. 31, 2023 1,190,843   $ 9   2,473,825   (2,678) (1,280,313)
Beginning balance, shares at Mar. 31, 2023     88,095,779          
Exercise of stock options 465       465      
Exercise of stock options, shares     30,371          
Vesting of restricted stock units, shares     151,853          
Issuance of shares under employee stock purchase plan 2,051       2,051      
Issuance of shares under employee stock purchase plan, shares     69,631          
Stock-based compensation 36,400       36,400      
Other comprehensive gain (loss) - unrealized gain (loss) on marketable securities (1,482)           (1,482)  
Other comprehensive gain (loss) - equity method investment 292           292  
Net Income (Loss) (123,681)             (123,681)
Ending balance at Jun. 30, 2023 1,104,888   $ 9   2,512,741   (3,868) (1,403,994)
Ending balance, shares at Jun. 30, 2023     88,347,634          
Beginning balance at Dec. 31, 2023 $ 1,050,169   $ 9   2,710,797   (2,258) (1,658,379)
Beginning balance, shares at Dec. 31, 2023 92,997,158   92,997,158          
Issuance of common stock   55,959   $ 1   55,958    
Issuance of common stock, shares       2,209,938        
Exercise of stock options $ 1,958       1,958      
Exercise of stock options, shares     110,734          
Vesting of restricted stock units, shares     1,015,543          
Stock-based compensation 34,176       34,176      
Other comprehensive gain (loss) - unrealized gain (loss) on marketable securities (821)           (821)  
Reclassification of other comprehensive loss - equity method investment 2,132           2,132  
Net Income (Loss) (107,436)             (107,436)
Ending balance at Mar. 31, 2024 1,036,137   $ 10   2,802,889   (947) (1,765,815)
Ending balance, shares at Mar. 31, 2024     96,333,373          
Beginning balance at Dec. 31, 2023 $ 1,050,169   $ 9   2,710,797   (2,258) (1,658,379)
Beginning balance, shares at Dec. 31, 2023 92,997,158   92,997,158          
Exercise of stock options, shares 190,246              
Other comprehensive gain (loss) - equity method investment $ 0              
Net Income (Loss) (254,411)              
Ending balance at Jun. 30, 2024 $ 971,062   $ 10   2,884,997   (1,155) (1,912,790)
Ending balance, shares at Jun. 30, 2024 98,289,150   98,289,150          
Beginning balance at Mar. 31, 2024 $ 1,036,137   $ 10   2,802,889   (947) (1,765,815)
Beginning balance, shares at Mar. 31, 2024     96,333,373          
Issuance of common stock   $ 38,399       $ 38,399    
Issuance of common stock, shares       1,592,823        
Exercise of stock options 1,179       1,179      
Exercise of stock options, shares     79,512          
Vesting of restricted stock units, shares     195,691          
Issuance of shares under employee stock purchase plan 1,669       1,669      
Issuance of shares under employee stock purchase plan, shares     87,751          
Stock-based compensation 40,861       40,861      
Other comprehensive gain (loss) - unrealized gain (loss) on marketable securities (208)           (208)  
Other comprehensive gain (loss) - equity method investment 0              
Net Income (Loss) (146,975)             (146,975)
Ending balance at Jun. 30, 2024 $ 971,062   $ 10   $ 2,884,997   $ (1,155) $ (1,912,790)
Ending balance, shares at Jun. 30, 2024 98,289,150   98,289,150